Acadia Pharmaceuticals reported $134.56M in Sales Revenues for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 134.56M 19.1M
ALKERMES ALKS:US $ 276.22M 2.33M
Alnylam Pharmaceuticals ALNY:US $ 224.82M 11.56M
Biogen BIIB:US $ 2589.1M 57.3M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bristol Myers Squibb BMY:US $ 11887M 239M
Cara Therapeutics CARA:US $ 23M 18.21M
Corcept Therapeutics CORT:US $ 103.39M 9.7M
Cytokinetics CYTK:US $ 88.97M 87.82M
Eisai 4523:JP Y 184262M 6639M
Eli Lilly And LLY:US $ 6488M 1322M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
Intra Cellular Therapies ITCI:US $ 55.58M 20.58M
Johnson & Johnson JNJ:US $ 24020M 594M
Marinus Pharmaceuticals MRNS:US 1.79M 12.4M
Moderna Inc MRNA:US 4.75B 1.32B
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Pfizer PFE:US $ 27742M 2081M
Prothena PRTA:US 1.31M 159K
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Seattle Genetics SGEN:US $ 497.5M 71.04M
Ultragenyx Pharmaceutical RARE:US $ 89.34M 9.41M
Vanda Pharmaceuticals VNDA:US $ 128.78M 68.59M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
YTE INCY:US $ 911.4M 178.16M